Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› San Giovanni Rotondo
Clinical trial register · Italy

Clinical Trials in San Giovanni Rotondo, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AbbVie6 Janssen Research & Development, LLC5 Pfizer4 Gruppo Oncologico del Nord-Ovest3 AstraZeneca3
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in San Giovanni Rotondo

70 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Gruppo Oncologico del Nord-Ovest
Phase 3
244
San Giovanni Rotondo, Tricase, Rozzano, Orbassano, Aviano, Bari, Bologna, Crema
2026-09-01
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
DrugPALI-2108
Palisade Bio
Phase 2
204
Bari, Bologna, Matera, Negrar, Rome, Rozzano, San Giovanni Rotondo, Turin
2026-08-28
Recruiting
Prilenia
Phase 3
400
Bologna, Milan, Naples, Padova, Roma, San Giovanni Rotondo
2026-07-01
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Alessandria, Brescia, Milan, Pisa, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo
2026-02-04
Recruiting
AstraZeneca
Observational
218
Monserrato, Cona, San Giovanni Rotondo, Rozzano, Ancona, Bari, Brescia, Florence
2025-12-31
Recruiting
Bristol-Myers Squibb
Phase 2/3
990
Castellana Grotte, San Giovanni Rotondo, Tricase, Milan, Aviano, Pisa, Padova, Avellino
2025-12-31
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Bologna, Florence, Milan, Negrar-Verona, Roma, Rozzano, San Giovanni Rotondo
2025-10-01
Recruiting
AbbVie
Phase 3
120
San Giovanni Rotondo, Naples, Rome, Trieste
2025-07-28
Recruiting
AbbVie
Observational
250
Castellana Grotte, Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Naples, Turin
2025-07-14
Recruiting
Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)
NCT06513273Acute Myeloid Leukemia, AML, Adult, Acute Myeloid Leukemia, Adult
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
397
San Giovanni Rotondo, Sassari
2025-07-11
Recruiting
Eikon Therapeutics
Phase 2/3
740
San Giovanni Rotondo, Alessandria, Messina, Milan, Modena, Padova, Trento, Genoa
2025-05-22
Recruiting
Genetic and Immunity in Heart Failure
NCT06758128Heart Failure
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
215
San Giovanni Rotondo, Rome
2025-02-04
Recruiting
Alimentiv Inc.
Not applicable
378
Castellana Grotte, Florence, Milan, Roma, Rome, San Giovanni Rotondo
2025-02-01
Recruiting
Takeda
Phase 3
396
Milan, Naples, Roma, Rozzano, San Giovanni Rotondo, Torino
2025-01-02
Recruiting
Shanghai Henlius Biotech
Phase 3
550
Caserta, Cremona, Naples, Rozzano, San Giovanni Rotondo, Torrette, Udine
2024-11-22
Recruiting
Gruppo Oncologico del Nord-Ovest
Phase 3
238
Brescia, Catania, Meldola, San Giovanni Rotondo, Florence, Tricase, Livorno, Lucca
2024-11-15
Recruiting
ThrombUS+
Observational
3,000
San Giovanni Rotondo
2024-11-06
Recruiting
Abivax S.A.
Phase 2
212
Bologna, Catanzaro, Milan, Negrar, Pavia, Roma, Rozzano, San Giovanni Rotondo
2024-10-30
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
196
Bergamo, Bologna, Roma, San Giovanni Rotondo, Trieste
2024-10-29
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
San Giovanni Rotondo, Monserrato, Viagrande, Bologna, Meldola, Monza, Frattamaggiore, Aviano
2024-09-27
Recruiting
AbbVie
Phase 2
590
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Rome, Turin, Negrar, Catanzaro
2024-09-04
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Foggia, San Giovanni Rotondo, Rozzano, Torino, Bologna, Catania, Messina, Milan
2024-09-04
Recruiting
AbbVie
Phase 3
110
San Giovanni Rotondo, Rome, Messina, Milan
2024-08-08
Recruiting
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
NCT06257706Moderately to Severely Active Crohn's Disease, Crohn Disease, Disease Crohn
DrugVedolizumab
Alimentiv Inc.
Phase 4
304
San Giovanni Rotondo, Milan, Roma
2024-08-07
Active, closed
Gruppo Oncologico del Nord-Ovest
Phase 2
16
Monserrato, Meldola, San Giovanni Rotondo, Tricase, Milan, Padova, Pisa, Prato
2024-07-23
Recruiting
Vor Biopharma
Phase 3
180
San Giovanni Rotondo, Naples, Cefalù, Pavia, Rome
2024-07-17
Recruiting
Biofeedback Based System to Enhance Robotic Assisted Gait Training in Children With Cerebral Palsy
NCT06947889Cerebral Palsy Infantile, Robotic Assisted Gait Training
G. d'Annunzio University
Observational
11
San Giovanni Rotondo
2024-07-01
Recruiting
A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced
NCT06467383Non-small Cell Lung Cancer, NSCLC, NSCLC, Stage III, NSCLC, Stage I
MSD Italia S.r.l.
Observational
600
San Giovanni Rotondo, Brescia, Campobasso, Catania, Florence, Genova, Messina, Milan
2024-06-25
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Bologna, Milan, Naples, Pontedera Pisa, Rho, Roma, Rozzano, San Giovanni Rotondo
2024-04-17
Active, closed
Cynata Therapeutics Limited
Phase 2
60
Ancona, Milan, Roma, Rozzano, San Giovanni Rotondo, Venezia
2024-03-04
Active, closed
AbbVie
Observational
1,200
Monserrato, San Giovanni Rotondo, Rozzano, Milan, Monza, Rome, Turin, Palermo
2024-02-19
Recruiting
Casa Sollievo della Sofferenza IRCCS
Phase 2
30
San Giovanni Rotondo, Novara, Padua, Palermo
2024-01-25
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Bergamo, Bologna, Florence, Pescara, Roma, San Giovanni Rotondo, Trieste
2024-01-19
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
124
Florence, Milan, Padova, Pisa, San Giovanni Rotondo, Verona
2024-01-03
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
San Giovanni Rotondo, Rozzano, Torino, Bologna, Foggia, Messina, Milan, Modena
2023-12-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,109
Monserrato, San Giovanni Rotondo, Rome, Milan, Rozzano, Rho, Naples, Palermo
2023-10-25
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
San Giovanni Rotondo, Meldola, Genoa, Alessandria, Turin, Candiolo, Ancona, Bologna
2023-09-18
Recruiting
Ipsen
Phase 3
276
Modena, Monza, Naples, Padova, Palermo, Pavia, Pisa, San Giovanni Rotondo
2023-08-31
Active, closed
Novartis Pharmaceuticals
Phase 2
144
Bologna, Milan, San Giovanni Rotondo
2023-08-25
Active, closed
Servier Affaires Médicales
Phase 3
299
Bologna, Florence, Milan, Naples, Reggio Emilia, Roma, Rozzano, San Giovanni Rotondo
2023-05-03
Active, closed
Genmab
Phase 3
900
Alessandria, Bari, Brescia, Bologna, San Giovanni Rotondo, Milan, Naples, Palermo
2023-02-08
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
San Giovanni Rotondo, Rho, Rozzano, San Donato Milanese, Negrar, Alessandria, Bologna, Brescia
2023-01-16
Active, closed
Ipsen
Phase 2
68
Modena, Padova, Palermo, Rozzano, San Giovanni Rotondo
2022-12-29
Active, closed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
NCT05611671Inflammatory Bowel Diseases, Colitis, Ulcerative
DrugZotemtegrast
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
280
Milan, Padova, Rozzano, San Giovanni Rotondo, Segrate
2022-11-21
Recruiting
Pfizer
Phase 3
1,060
Meldola (Fc), Piacenza, Ravenna, San Giovanni Rotondo, Aviano, Monza, Turin, Palermo
2022-11-10
Active, closed
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095Fistulizing Crohns Disease, Perianal Crohns Disease
DrugGuselkumab
Janssen-Cilag Ltd.
Phase 3
288
Milan, Negrar ( Ve), Pisa, Rho, Roma, Rozzano, San Giovanni Rotondo
2022-09-27
Active, closed
Genmab
Phase 3
549
San Giovanni Rotondo, Milan, Turin, Aviano, Rome, Candiolo, Alessandria, Bari
2022-09-20
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
845
San Giovanni Rotondo, Milan, Rozzano, Roma, Torino, Florence, Palermo, Pisa
2022-08-26
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsAbraxane·Nab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
San Giovanni Rotondo, Meldola, Reggio Emilia, Milan, Candiolo, Pisa, Terni, Verona
2022-08-08
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Naples, San Giovanni Rotondo, Genoa, Rozzano, Candiolo, Pisa, Bari, Brescia
2022-07-14
Active, closed
Pfizer
Phase 2
108
Monserrato, Naples, Guastalla, San Giovanni Rotondo, Milan, Candiolo, Livorno, Pisa
2022-07-11
Recruiting
CytOSorb TreatMent Of Critically Ill PatientS Registry
NCT05146336Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis
CytoSorbents, Inc
Observational
3,000
Roma, San Giovanni Rotondo
2022-06-22
Recruiting
Priothera SAS
Phase 3
366
Brindisi, Reggio Calabria, San Giovanni Rotondo, Lecce, Roma, Alessandria, Ascoli Piceno, Florence
2022-06-16
By invitation
Casa Sollievo della Sofferenza IRCCS
Observational
1,000
San Giovanni Rotondo
2022-03-10
Active, closed
Inventiva Pharma
Phase 3
1,000
San Giovanni Rotondo, Milan, Naples, Palermo, Roma, Bologna, Novara, Torino
2021-08-19
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
72
Bologna, Bolzano, Castelfranco Veneto, San Giovanni Rotondo, Treviso
2021-06-09
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, San Giovanni Rotondo, Bari, Cagliari, Novara, Palermo, Reggio Emilia, Terni
2021-05-20
Active, closed
Pfizer
Phase 3
599
Bologna, Cremona, Meldola, San Giovanni Rotondo, Naples, Aviano, Trento, Arezzo
2021-05-12
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Catanzaro, San Giovanni Rotondo, Palermo, Bologna, Florence, Foggia, Milan, Roma
2021-04-01
Active, closed
IRCCS San Raffaele Roma
Not applicable
70
Bologna, Ferrara, Foggia, Messina, Roma, Rome, San Giovanni Rotondo
2020-12-28
Active, closed
Pfizer
Phase 3
841
Monserrato (CA), San Giovanni Rotondo, Milan, Candiolo, Orbassano, Brescia, Naples, Padova
2020-12-21
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
100
Brescia, San Giovanni Rotondo, Tricase, Monza, Ancona, Ascoli Piceno, Bari, Bologna
2019-12-09
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
San Giovanni Rotondo, Bari, Bergamo, Bologna, Cagliari, Catania, Florence, Genova
2019-10-09
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bologna, Florence, Messina, Roma, San Giovanni Rotondo, Trieste
2018-10-29
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Milan, Palermo, Rozzano, San Giovanni Rotondo
2016-12
Active, closed
AstraZeneca
Phase 3
1,126
Arezzo, Meldola, Milan, Naples, Orbassano, Pavia, Roma, San Giovanni Rotondo
2015-11-02
Active, closed
AstraZeneca
Phase 3
1,118
Genova, Meldola, Milan, San Giovanni Rotondo, Siena
2015-07-21
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Ancona, Bari, Bologna, Brescia, San Giovanni Rotondo, Florence, Milan, Rozzano
2015-03-05
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Sesto Fiorentino, Milan, Florence, Pisa, Rome, San Giovanni Rotondo
2015-01-20
Active, closed
AbbVie
Observational
8,250
Bologna, Florence, San Giovanni Rotondo, Genoa, Rozzano, Milan, Naples, Rome
2013-04-29
Rows per page Showing 1–70 of 70
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/san-giovanni-rotondo

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 70 of those studies with a site in San Giovanni Rotondo.

How many clinical trials are recruiting in San Giovanni Rotondo?

35 of the 70 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 32 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (San Giovanni Rotondo), 70 studies
PhaseStudiesRecruitingShare
Phase 3361751.4%
Observational14820%
Phase 212517.1%
Not applicable314.3%
Phase 2/3334.3%
Phase 4212.9%

Most active sponsors

Lead sponsors with the most studies (San Giovanni Rotondo)
Lead sponsorStudiesRecruiting
AbbVie64
Janssen Research & Development, LLC53
Pfizer41
AstraZeneca31
Gruppo Oncologico del Nord-Ovest31
Abivax S.A.21
Akero Therapeutics, Inc22
Alexion Pharmaceuticals, Inc.20
Alimentiv Inc.22
Casa Sollievo della Sofferenza IRCCS21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.